OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Curcumin Analogs PGV-1 and CCA-1.1 Induce Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells with Overexpressed MYCN
Moordiani Moordiani, Dhania Novitasari, Ratna Asmah Susidarti, et al.
The Indonesian Biomedical Journal (2023) Vol. 15, Iss. 2, pp. 141-9
Open Access | Times Cited: 5
Moordiani Moordiani, Dhania Novitasari, Ratna Asmah Susidarti, et al.
The Indonesian Biomedical Journal (2023) Vol. 15, Iss. 2, pp. 141-9
Open Access | Times Cited: 5
Showing 5 citing articles:
Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells
Dhania Novitasari, Riris Istighfari Jenie, Jun‐ya Kato, et al.
Research in Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 358-370
Open Access | Times Cited: 8
Dhania Novitasari, Riris Istighfari Jenie, Jun‐ya Kato, et al.
Research in Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 358-370
Open Access | Times Cited: 8
Tumour‐suppressive effects of curcumin analogs CCA‐1.1 and Pentagamavunone‐1 in colon cancer: In viv o and in vitro studies
Febri Wulandari, Muthi Ikawati, Sitarina Widyarini, et al.
Journal of Advanced Pharmaceutical Technology amp Research (2023) Vol. 14, Iss. 4, pp. 317-324
Open Access | Times Cited: 5
Febri Wulandari, Muthi Ikawati, Sitarina Widyarini, et al.
Journal of Advanced Pharmaceutical Technology amp Research (2023) Vol. 14, Iss. 4, pp. 317-324
Open Access | Times Cited: 5
Pentagamavunone-1 inhibits aggressive breast cancer cell proliferation through mitotic catastrophe and ROS-mediated activities: in vitro and in vivo studies
Dhania Novitasari, Ikuko Nakamae, Riris Istighfari Jenie, et al.
Saudi Pharmaceutical Journal (2023) Vol. 32, Iss. 1, pp. 101892-101892
Open Access | Times Cited: 2
Dhania Novitasari, Ikuko Nakamae, Riris Istighfari Jenie, et al.
Saudi Pharmaceutical Journal (2023) Vol. 32, Iss. 1, pp. 101892-101892
Open Access | Times Cited: 2
The Combination of Sorafenib and PGV‐1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c‐Myc Suppression in an Additive Manner: In Vitro Studies
Dhania Novitasari, Ikuko Nakamae, Noriko Yoneda‐Kato, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access
Dhania Novitasari, Ikuko Nakamae, Noriko Yoneda‐Kato, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access
Different Mitotic Arrest Targets of Chemoprevention Curcumin Analog 1.1 (CCA-1.1) and Pentagamavunone-1 (PGV-1) in Leukemic K-562 Cells
Riris Istighfari Jenie, Dhania Novitasari, Dyaningtyas Dewi Pamungkas Putri, et al.
Pharmaceutical Sciences (2024)
Open Access
Riris Istighfari Jenie, Dhania Novitasari, Dyaningtyas Dewi Pamungkas Putri, et al.
Pharmaceutical Sciences (2024)
Open Access
